Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
Aging · 2023
DOI: 10.18632/aging.205104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Xugang Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rehabilitation Medicine, Cancer Center, Department of Orthopedics, Zhejiang Provincial People’s Hospital affiliated to Qingdao University,…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rehabilitation Medicine, Cancer Center, Department of Orthopedics, Zhejiang Provincial People’s Hospital affiliated to Qingdao University, Qingdao, Shandong, China.
- Center for Rehabilitation Medicine, Department of Orthopedics, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zitieren
APA
Zhong, X., He, Z., Fan, Y., Yin, L., Hong, Z., Tong, Y., Bi, Q., & Zhu, S. (2023). Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.205104
Vancouver
Zhong X, He Z, Fan Y, Yin L, Hong Z, Tong Y, et al. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. Aging. 2023. doi:10.18632/aging.205104
BibTeX
@article{Zhong2023,
author = {Zhong, Xugang and He, Zeju and Fan, Yong and Yin, Li and Hong, Zheping and Tong, Yu and Bi, Qing and Zhu, Senbo},
title = {Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205104}
}
EUVIMED